awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35076351-0B90AE15-E8CE-4EFC-8020-185DB7136D84
Q35076351-0B90AE15-E8CE-4EFC-8020-185DB7136D84
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35076351-0B90AE15-E8CE-4EFC-8020-185DB7136D84
Bevacizumab in metastatic breast cancer: when may it be used?
P2860
Q35076351-0B90AE15-E8CE-4EFC-8020-185DB7136D84
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35076351-0B90AE15-E8CE-4EFC-8020-185DB7136D84
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
60d5ec21c0f59487748ae421060a12cf6cee74b6
P2860
Phase III study of bevacizumab plus docetaxel compared with placebo plus docetaxel for the first-line treatment of human epidermal growth factor receptor 2-negative metastatic breast cancer.